Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Faculty Opinions recommendation of Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature(2008)10.3410/f.1120004.586903Source: DataRank Database

Faculty Opinions recommendation of Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. is a research paper published in Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature (2008). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:OA: closedTopics (13)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Keo Tabane,Daniel Vorobiof

Live enrichment

PubMed:23304386 OpenAlex:https://openalex.org/W4250822077

closed

repositoryhttps://doi.org/10.3410/f.1120004.586903

Fields of Study

Lung Cancer Treatments and MutationsHepatocellular Carcinoma Treatment and PrognosisLung Cancer Diagnosis and Treatment

Keywords

PemetrexedGemcitabineCisplatinOncologyLung cancerInternal medicineMedicineChemotherapyStage (stratigraphy)Biology

Sustainable Development Goals

SDG 0: Good health and well-being

Faculty Opinions recommendation of Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

FAIR Checklist

Authors (2)

Open Access

Topics